Sign In
Home
About Us
Benefits
Pricing
Krixos Global Intel
Krixos
Contact Us
Breaking Cancer News A-Z
Health/Pharma Companies
Drugs, Treatments, Trials
Hot Topics
Clinical Trials - Latest News
Other Illnesses & Conditions
Latest Healthcare News
My Settings
Client Requests
Advanced Search
My Viewed Articles
All Cancer News
Acute Lymphoblastic Leukemia
Acute myeloid leukemia
Adenocarcinoma
Adenoid Cystic Carcinoma
Adrenocortical Carcinoma
Anal Cancer
Anaplastic Astrocytoma
Angiosarcoma
Astrocytoma
Basal-Cell Carcinoma
Bladder Cancer
Brain Cancer
Breast Cancer
Cancer Cachexia
Carcinoma
Cervical Cancer
Childhood Cancer
Cholangiocarcinoma
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Colorectal Adenocarcinoma
Colorectal Cancer
Craniopharyngioma
Endometrial Cancer
Ependymoma
Esophageal Cancer
Ewing's Sarcoma
Gallbladder Cancer
Germ Cell Tumors
Glioblastoma
Glioma
Hairy Cell Leukemia
Hepatocellular Carcinoma
Hodgkin Lymphoma
Kaposi's Sarcoma
Kidney & Renal Cancer
Laryngeal Cancer
Leukemia
Liver Cancer
Lung Adenocarcinoma
Lung Cancer
Lymphoma
Mantle Cell Lymphoma
MCRPC
Medulloblastoma
Melanoma
Meningioma
Mesothelioma
Metastatic Colon Cancer
Mouth Cancer
Multiple Myeloma
Myelodysplastic Syndrome
Myelofibrosis
Nasopharyngeal Carcinoma
Neuroblastoma
NMIBC
Non-Hodgkin Lymphoma
NSCLC
Oral Cancer
Oropharyngeal Cancer
Osteosarcoma
Ovarian Cancer
Pancreatic Adenocarcinoma
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Penile Cancer
Pheochromocytoma
Prostate Cancer
Retinoblastoma
Rhabdomyosarcoma
Sarcoma
Sarcopenia
Skin Cancer
Small Cell Lung Cancer
Squamous Cell Carcinoma
Stomach (Gastric) Cancer
Synovial Sarcoma
Testicular Cancer
Thymic Carcinoma
Thymoma
Thyroid Cancer
Tongue Cancer
Uterine Cancer
Vulvar Cancer
Waldenstrom Macroglobulinemia
You need to login...
Enter your email:
Enter your password:
If you are not registered...
Subscribe to Krixos Health:
Sign Up Now:
Your email:
or call us on: +43 (0)1 27 63 015
or email:
subscribe@krixos.com
Most viewed
1.
Basal Cell Carcinoma Treatment Market Set to Reach USD 8.96 Billion by 2032 – SNS Insider
2.
Size matters: a review of the challenges in and importance of multimodal approaches to the management of patients with small, node-negative, triple-negative breast cancer
3.
[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
4.
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds
5.
Long-term locoregional outcomes in a contemporary cohort of young women with breast cancer
6.
Powerlifting through breast cancer – how a breast cancer survivor defied chemotherapy with strength training
7.
Differences in the distribution of HER2-positive breast tumors according to ethnicity and genetic variants in ERBB2: a special focus on Asian and Latina women
8.
Identification of SMYD2 as a candidate diagnostic and prognostic biomarker for gastric cancer
9.
Decoding colorectal cancer lung metastasis: a global research odyssey
10.
Global research landscape of antiangiogenic therapy for colorectal cancer: a bibliometric analysis of mechanistic insights and clinical advancements
Last updated at 3:54 GMT
Hot News Makers
Health/Pharma Companies
Abivax
74416.84
Roche
37819.72
UnitedHealth Group
13822.41
Replimune
10071.68
Kiniksa Pharmaceuticals
5612.19
BioNTech
5549.67
MicroPort
5114.56
National Institutes of Health
4975.47
Astra Zeneca
4823.82
Food & Drug Administration
4637.63
Drugs, Treatments, Trials
Nivolumab
45816.60
Ligufalimab
8424.11
Xelox
7425.26
Irinotecan
6955.47
Gemcitabine
4107.83
Fluorouracil
4056.88
Bleomycin
3814.88
Paclitaxel
3479.24
Bevacizumab
3339.77
Capecitabine
3308.08
Last updated at 3:10 GMT